Description

Body Pharm Melanotan II 20 Pen: Dosing Guide & Review

The Body Pharm Melanotan II 20 Pen is a 20 mg prefilled, dial-a-dose tanning peptide sold in South Africa with no published micrograms-per-click (mcg-per-click) specification from Body Pharm or Beskinny [1][4]. Because the manufacturer does not specify dose-per-click, you must back-calculate practical dosing from the label and adapt it from established MT-II vial protocols — which is exactly what this guide covers.

Key Takeaways

• The Body Pharm 20 Pen delivers 20 mg of Melanotan II in prefilled form with no manufacturer-published mcg-per-click spec; you must back-calculate the dose from cartridge volume.
• A standard protocol uses three phases: tolerance (100 mcg daily for 3–5 days), loading (250–500 mcg daily for 1–3 weeks), and maintenance (100–250 mcg twice weekly).
• The pen format eliminates reconstitution and reduces waste compared to vials, but the side-effect profile (nausea, flushing, priapism, mole changes) is identical to vial-delivered MT-II.
• MT-II is unregistered with SAHPRA and unapproved by the TGA, FDA, and EMA as of 2026; regulatory status varies by jurisdiction and should be verified before purchase.
• Serious adverse events include priapism, melanoma induction, and neurological symptoms; dermatology screening before and during use is essential.

MT-II remains unregistered with SAHPRA as of 2026 [16] and unapproved by the TGA, FDA and EMA [5][8]. Read accordingly.

What Is the Body Pharm Melanotan II 20 Pen?

The Body Pharm Melanotan II 20 Pen is a 20 mg prefilled, no-mix subcutaneous injection pen containing synthetic Melanotan II in solution, sold in South Africa by Beskinny for R1,400.00 with 10 units in stock as of 2026 [1][4]. Because the peptide arrives reconstituted, you skip the bacteriostatic-water-and-vial step that vial users handle and dial doses directly from the pen.

What’s in the box and what it does:

• Active: 20 mg Melanotan II, a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) [5][6].
• Format: Prefilled dial-a-dose pen, solution form, no reconstitution [1][3].
• Mechanism: Activates melanocortin receptors. MC1R drives melanogenesis (pigmentation), while MC3R and MC4R activity is linked to libido and appetite effects reported in user literature [5][6]. Receptor-subtype attribution for pen-format products specifically remains unverified in peer-reviewed studies [7].
• Price and availability: R1,400.00, 10 in stock at Beskinny, 2026 [1].
• Regulatory status: Not registered with SAHPRA [8]. Not approved by the TGA, FDA, or EMA [5][10][12]. The TGA publicly warned consumers to avoid Melanotan II in a UNSW Newsroom article dated January 30, 2023 [5].

Cross-shopping the Body Pharm pen range? The Body Pharm CJC1295 & Ipamorelin 20 Pen and Body Pharm MOTS-C 32 Pen use the same prefilled dial-a-dose hardware, so the back-calculation method covered later in this guide carries over.

Pen vs. Vial: Why Format Matters for MT-II

The pen wins on reconstitution, dosing accuracy and waste because the cartridge arrives ready to inject and delivers consistent micro-increments per click. The vial wins on per-mg cost and dose flexibility above 1 mg because you can draw any volume from a larger reservoir. No peer-reviewed pharmacokinetic study has compared pen-delivered MT-II to vial-delivered MT-II as of 2026 [3], so the comparison below draws from product specifications and community-reported protocols from 2024–2025 [4][6][11].

Reconstitution required — Vial: yes, you mix lyophilised powder with bacteriostatic water, and wrong-volume errors directly shift your mcg-per-unit on the insulin syringe [8]. Pen: no, the Body Pharm 20 Pen ships as a solution [4].

Dosing accuracy — Vial: depends on your reconstitution maths and how cleanly you read a 0.5 mL insulin syringe at 5–10 IU marks. Pen: dial-a-dose mechanics deliver the same click volume each time, though the exact mcg-per-click for the Body Pharm 20 Pen is not published by the manufacturer and must be back-calculated [7].

Peptide waste risk — Vial: higher. MT-II is sensitive to temperature shock and repeated needle entry. Reconstituted vials degrade once opened, so a 10 mg vial that you only half-use during a maintenance phase often hits its stability window before you finish it [2]. Pen: lower, because the cartridge stays sealed between doses.

Travel convenience — Vial: you carry powder, bacteriostatic water, alcohol swabs, insulin syringes and a sharps container. Pen: one device plus pen needles.

Time per administration — Vial: roughly 2–4 minutes once reconstituted (draw, tap, inject). Pen: under 60 seconds (dial, prime, inject).

Cross-shopping prefilled formats? The Body Pharm CJC1295 & Ipamorelin 20 Pen and Body Pharm MOTS-C 32 Pen share the same hardware logic, so the trade-offs above apply across the range.

How Melanotan II Works: The Science in Plain Terms

Melanotan II produces a tan by mimicking alpha-melanocyte-stimulating hormone and binding melanocortin receptors on melanocytes, which upregulates melanin synthesis (melanogenesis) and deepens baseline pigmentation [6]. The pen format changes the delivery hardware, not the pharmacology.

The mechanism breaks down into four steps:

• MC1R binding in skin — MT-II is an analogue of α-MSH, so it activates MC1R on melanocytes and pushes them to produce more eumelanin (the brown/black pigment) [6].
• UV is still required — MT-II amplifies the tanning response; it does not replace sunlight or a sunbed. Without UV exposure, the upregulated melanocytes have no trigger to fully express the darker pigment [6].
• MC4R activation in the central nervous system — the same peptide hits MC4R in the brain, which is why users report appetite suppression, nausea, and spontaneous erections within 1–4 hours of injection [5][6].
• Pen delivery is still subcutaneous — no post-2023 study has assessed pen-format pharmacokinetics specifically, so absorption is assumed to match standard subcutaneous injection from a vial [7].

The side-effect profile (flushing, nausea, darkening moles, priapism) results from this receptor promiscuity, not a formulation quirk of the Body Pharm Melanotan II 20 Pen range [5][6].

Melanotan II 20 Pen Dosing Protocol (Step-by-Step)

The pen-format MT-II protocol below follows three phases — tolerance, loading, maintenance — using community-reported dose ranges, not clinically validated figures [1][4]. No peer-reviewed study has assessed pen-delivered Melanotan II pharmacokinetics, so treat every number here as informational and consult a healthcare professional before injecting [11].

Tolerance Phase (Days 1–5) — Dial the lowest setting the pen permits (commonly the equivalent of 100 mcg on a 20 mg pen, based on user back-calculation of cartridge volume; the manufacturer does not publish a mcg-per-click spec) [5][6]. Inject subcutaneously into the abdomen or thigh in the evening so the predictable nausea, flushing and yawning hit while you sleep [5][6]. Hold this dose for 3–5 consecutive evenings to gauge how your body handles MC4R activation before scaling.

Loading Phase (roughly Weeks 1–3) — Increase by one dial increment every 2–3 days, daily, working toward the 250–500 mcg/day range that dominates 2024–2026 grey-literature protocols [1][4]. Pair each dose with 15–20 minutes of moderate UV (sunlight or sunbed) within 24 hours, because MT-II amplifies melanogenesis but cannot trigger pigment without UV exposure [1][6]. Stop escalating once the mirror shows the depth you want, even if that’s below 500 mcg. Most users report visible darkening within 1–3 weeks at these doses [1].

Maintenance Phase (ongoing) — Drop to 100–250 mcg, twice weekly, and cut UV sessions proportionally to hold the colour [1]. If pigmentation fades, add a third weekly dose before raising the per-injection amount. Pause entirely if new moles appear or existing moles darken, and get a dermatology review. Melanocytic changes are the most consistently reported adverse signal in post-2023 commentary [9][10].

Quick-reference dosing table

Figures adapted from 2024 RevitalizeMD protocol guidance and 2023–2025 reseller/forum summaries [1][4]. Not endorsed by Body Pharm, SAHPRA, FDA or TGA [6][9][13].

Why the pen helps with micro-dosing accuracy

A prefilled dial-a-dose pen delivers the same micro-increment every click. That repeatability matters most in the tolerance phase, where a 50–100 mcg overshoot is the difference between mild flushing and a night of vomiting [5][6]. It’s a genuine practical advantage over reconstituting a 10 mg vial and chasing 5–10 IU marks on an insulin syringe. Already comfortable with the pen format from other peptides? The Body Pharm CJC1295 & Ipamorelin 20 Pen or Body Pharm MOTS-C 32 Pen click mechanics carry over directly.

How to Use the Prefilled Pen: Administration Tips

Inject subcutaneously into the abdomen or outer thigh by pinching the skin, inserting at 90°, holding the dose button until the click stops, then counting three seconds before withdrawing. The prefilled cartridge skips the air-bubble purge that vial reconstitution requires, which is the main hands-on time saving over a 10 mg vial workflow [1].

Steps on a fresh pen:

1. Inspect the cartridge through the window. The solution should be clear and colourless. Discard if cloudy or particulate.
2. Attach a new pen needle (typically 4–8 mm, 31–32G) and remove both caps.
3. Prime with one click into the air on first use to clear the needle dead-space. Subsequent doses don’t need re-priming the same day [1].
4. Dial the target dose. Wipe the chosen injection site (lower abdomen at least 5 cm from the navel, or outer thigh) with an alcohol swab.
5. Pinch a fold of skin, insert fully, press the dose button until it stops clicking, hold 3–5 seconds, then withdraw.
6. Dispose of the needle in a rigid sharps container. Never re-cap by hand.

Store the pen at 2–8°C between uses, upright, with the needle removed and the cap on. Do not freeze, and keep it out of direct light. Rotating it with a Body Pharm CJC1295 & Ipamorelin 20 Pen or Body Pharm MOTS-C 32 Pen? Label the caps — the bodies look identical in a fridge door.

Side Effects: What to Expect and How to Manage Them

Most users report mild, transient side effects from Melanotan II: nausea, facial flushing, spontaneous yawning, increased libido, and temporary appetite suppression [1][11]. Slow titration is the single most effective mitigation because it allows your system to acclimatise to MC4R activation before you push toward higher doses. The 100 mcg starting dose and gradual loading protocol described earlier exist specifically for this reason.

Timing matters. Inject in the evening, preferably after food, so the nausea peak (typically 1–3 hours post-dose) overlaps with sleep rather than your working day. If flushing is the dominant complaint, a single non-drowsy antihistamine 30 minutes pre-dose is a common community workaround, though no controlled data supports it [17].

Serious adverse events

Documented serious events are rare but real. Mallory et al. (2021) published a priapism case linked to MT-II use, and DermNet’s 2023 monograph catalogues additional reports of new or darkening moles, suspected melanoma induction, melanonychia, rhabdomyolysis, and encephalopathy in long-term users [1]. The 2023 UNSW/TGA commentary reiterates that MT-II development was halted partly on safety grounds and lists neurological symptoms among reported reactions [2].

Stop dosing and seek medical attention for: an erection lasting over four hours, chest pain or palpitations, severe persistent vomiting, sudden neurological symptoms, or any mole that changes shape, colour, or size. Get a full skin check from a dermatologist before starting and again annually if you continue past one tanning season [1].

What the data does not tell you

No randomised controlled trial has assessed side-effect incidence for pen-format MT-II delivery specifically [10]. Every percentage you’ll see quoted online traces back to small early-phase studies of vial-reconstituted peptide or to self-reported forum data [16][17]. The pen changes how accurately you dose, not the molecule’s pharmacology, so the risk profile is the same as conventional MT-II injection.

Regulatory Status and Legal Considerations (2026)

Melanotan II is not an approved medicine in any major jurisdiction as of 2026, and South Africa is no exception. SAHPRA has no record of MT-II or afamelanotide as a registered therapeutic product, and Body Pharm’s pen is sold as a research or cosmetic peptide rather than a licensed drug [1][9].

What the major regulators say

• TGA (Australia): A January 2023 UNSW/TGA-linked advisory urges consumers not to use Melanotan II, citing halted clinical development on safety grounds and ongoing enforcement against online suppliers [4].
• FDA (US): MT-II is classed with unapproved injectable tanning products in consumer advisories through 2024. Importation for personal use remains illegal [6].
• EMA / UK MHRA: No licensed MT-II product exists in the EU or UK, and national agencies continue to warn against online supply with no new standalone guidance issued post-2023 [7].
• SAHPRA (South Africa): No registration, no published scheduling notice specific to MT-II, and no approved indication. Sale as a “tanning peptide” sits outside the Medicines Act framework [1].

Peer-reviewed literature describes MT-II as unlicensed and largely untested [3]. Legal status shifts. Verify your jurisdiction before ordering, and treat anything written before 2023 as potentially stale.

This guide is informational. It is not medical advice, not a therapeutic recommendation, and not an endorsement of MT-II use. Comparing other pen-format peptides on the same platform? The Body Pharm CJC1295 & Ipamorelin 20 Pen and Body Pharm MOTS-C 32 Pen sit in the same prefilled-pen category and carry their own regulatory caveats.

Who Is the Body Pharm Melanotan II 20 Pen Best For?

The Body Pharm Melanotan II 20 Pen suits adults who have already decided to use MT-II and want a prefilled, no-reconstitution format with dial-adjustable micro-doses, accepting that it is an unregistered substance in South Africa [8]. It is a convenience and dose-accuracy choice, not a safer molecule.

Good fit

• You’ve used vials before and burned product through bad reconstitution, dropped insulin syringes, or inconsistent draws.
• You travel and want a single sealed device rather than bacteriostatic water, syringes, and a 10 mg vial in transit.
• You want repeatable micro-doses (typically 100–250 mcg ranges cited in 2024 clinic protocols [10]) without the maths each evening.
• You’re already running other prefilled peptide pens like the Body Pharm CJC1295 & Ipamorelin 20 Pen or Body Pharm MOTS-C 32 Pen and want format consistency.

Poor fit, or stop and see a doctor first

• Personal or family history of melanoma, atypical naevi, or numerous moles. DermNet’s 2023 monograph flags new and darkening moles plus possible melanoma induction as documented MT-II concerns [6].
• Cardiovascular disease, uncontrolled hypertension, or a history of priapism. Reported adverse events include priapism and systemic symptoms such as nausea and flushing [5][6].
• Pregnancy, breastfeeding, or active attempts to conceive.
• Residence or transit through jurisdictions where MT-II supply is explicitly illegal (Australia, UK, EU, US) [5][6].

Get a clinician to screen your skin and cardiovascular status before you open the pen. The convenience of the format does not change the underlying risk profile.

Body Pharm Melanotan II 20 Pen: Key Specs at a Glance

The Body Pharm Melanotan II 20 Pen is a prefilled subcutaneous injection pen containing 20 mg of Melanotan II, sold via Beskinny.store for R1,400.00 as of 2026 [3].

Body Pharm does not publish an official mcg-per-click figure for this pen, so the click value must be back-calculated from cartridge volume once the device is in hand [2]. Format-consistent alternatives in the same range include the Body Pharm CJC1295 & Ipamorelin 20 Pen and the Body Pharm MOTS-C 32 Pen.

Frequently Asked Questions

Does the pen require refrigeration? Yes. Store the Body Pharm Melanotan II 20 Pen at 2–8 °C, do not freeze, and keep it protected from light [3]. A bedroom drawer is not adequate because temperature fluctuations degrade the peptide. Once in use, keep the pen in the fridge between injections and let it sit at room temperature for a minute or two before dosing to reduce sting.

Do I still need UV exposure? Yes. Melanotan II amplifies melanogenesis but does not replace sunlight. Without moderate UV (sun or a tanning bed), pigment response is minimal regardless of dose [4][8]. Most South African users report visible darkening only after combining dosing with 10–20 minutes of UV every 2–3 days, though this is community-reported, not clinically established [15].

How long does a 20 mg pen last? Roughly 4–10 weeks depending on phase and individual dose. At a community-reported loading dose of 250–500 mcg daily, a 20 mg pen lasts about 40–80 days. On maintenance at 100–250 mcg two to three times weekly, the same pen can stretch past three months [12][15]. Treat these as user-derived estimates, not manufacturer figures [16].

Can I use the pen if I have fair skin? Skin type affects response significantly. Fitzpatrick I–II users typically need a longer loading phase and report a higher incidence of new or darkening moles, nausea and facial flushing at standard doses [3][4]. Starting at the low end of the micro-dose range (50–100 mcg) and extending the loading window is the commonly cited approach, though again this is community practice rather than clinical guidance [15].

Is Melanotan II the same as Melanotan I? No. MT-II is a shorter, cyclic, more potent analogue that activates MC1R, MC3R, MC4R and MC5R, which is why side effects like nausea, flushing and spontaneous erections are reported [3][14]. Melanotan I (afamelanotide) is more selective for MC1R and is the only melanocortin agonist with any regulatory approval, used for erythropoietic protoporphyria rather than cosmetic tanning [4].

Comparing the full prefilled pen range? The Body Pharm CJC1295 & Ipamorelin 20 Pen and Body Pharm MOTS-C 32 Pen use the same device format and storage requirements.

Next Steps

Before ordering the Body Pharm Melanotan II 20 Pen, verify that MT-II supply is legal in your jurisdiction, book a dermatology appointment to assess your baseline skin status and mole count, and have your cardiovascular health screened by a clinician. Once you’ve confirmed regulatory compliance and medical clearance, purchase from Beskinny.store, follow the tolerance-phase protocol starting at 100 mcg, and schedule a follow-up skin check within 4–6 weeks of starting maintenance dosing.